Evidence map›Paper›PMID 29126613›Full record

ArticleFertility and sterility2017

Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study.

Laura D Almquist, Creighton E Likes, Benjamin Stone, Kaitlin R Brown, Ricardo Savaris, David A Forstein, Paul B Miller, Bruce A Lessey

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Fertility and sterility, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04039204 phase2completednot on this mapstarted 2022, after this paper: background citation

Elagolix for Fertility Enhancement Clinical Trial (EFFECT)

TypeinterventionalSponsorWake Forest University Health SciencesRan2022 to 2023Enrolled10ConditionsEndometriosis, Unexplained InfertilityArmsElagolix, Ortho Cyclen
NCT04184323 phase2withdrawnnot on this mapstarted 2022, after this paper: background citation

SIRT1-1 Antagonist Therapy Before Embryo Transfer to Improve Endometrial Receptivity and Life Pregnancy Rates

TypeinterventionalSponsorWake Forest University Health SciencesRan2022 to 2023Enrolled0ConditionsEndometriosis, Uterine Diseases, Endometrial Diseases, Infertility UnexplainedArmsEX-527 (Selisistat), Placebo
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Endometriosis: An Immunologist's Perspective.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Laura D AlmquistDepartment of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina.
Creighton E LikesDepartment of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina.
Benjamin StoneDepartment of Biology, Bowdoin College, Brunswick, Maine.
Kaitlin R BrownObstetrics and Gynecology, University of South Carolina SOM-Greenville, Greenville, South Carolina.
Ricardo SavarisDepartamento de Ginecologia e Obstetrícia, Universidade Federal do Rio Grande do Sul, Rio Grande do Sul, Brazil.
David A ForsteinDepartment of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina.
Paul B MillerDepartment of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina.
Bruce A LesseyDepartment of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina. Electronic address: blessey@ghs.org.
Prisma Health · USBowdoin College · USUniversidade Federal do Rio Grande do Sul · BRUniversity of South Carolina · US

Funding

Progesterone Action in the Endometrium of Women with EndometriosisR01HD067721 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YOUNG, STEVEN L · 2011 to 2015
$3.1M
NICHD NIH HHS R01 HD067721
6 · The paper itself

Abstract

objectiveTo evaluate endometrial BCL6 expression as a prognostic biomarker for IVF outcome in women with unexplained infertility (UI) before ET.

designProspective cohort study.

settingUniversity-associated infertility clinic. PATIENT(S): Women with UI for >1 year. INTERVENTION(S): We studied women with UI who underwent testing for endometrial BCL6, in an LH-timed midluteal phase biopsy and completed an IVF cycle and ET. MAIN OUTCOME MEASURE(S): Clinical pregnancy rate (PR) and live birth rate per transfer was compared for women positive or negative for BCL6 expression. An abnormal BCL6 result was defined by an histologic score (>1.4). RESULT(S): Women with normal and abnormal BCL6 and those who conceived or not had similar characteristics. Women with low levels of BCL6 expression had a significantly higher clinical PR (11/17; 64.7%; 95% confidence interval [CI] 41.3-82.6) compared with women with abnormal (high) BCL6 expression (9/52; 17.3%; 95% CI 9.3-30.8). These results yield a relative risk of 0.267 (95% CI 0.13-0.53; P=.0004) for those with normal BCL6 expression, an absolute benefit of 47.4% (95% CI 22.5-72.0). Live birth rate was also significantly higher in women with low BCL6 expression (10/17; 58.8%; 95% CI 36.0-78.4) compared with women with abnormal BCL6 expression (6/52; 11.5%; 95% CI 5.4-23.0). The relative risk was 0.19 (95% CI 0.08-0.45; P=.0002), yielding an absolute benefit of 47.3% (95% CI 21.8-67.8). CONCLUSION(S): Aberrant BCL6 expression (histologic score, >1.4) was strongly associated with poor reproductive outcomes in IVF cycles in women with UI.

Indexed as

Fertilization in VitroAdultBiomarkersEndometriumFemaleFertilityHumansInfertility, FemaleLive BirthPregnancyPregnancy RateProspective StudiesProto-Oncogene Proteins c-bcl-6Risk FactorsTreatment OutcomeBCL6 protein, humanBiomarkersProto-Oncogene Proteins c-bcl-6BCL6EndometriumIVFpregnancyprognosis

Identifiers

PMID29126613
PMCPMC5726554
OpenAlexW2767405034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.